Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response have?
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response has 414 citations in the OpenAlex counts ScholarIQ stores.
When was Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response published?
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response has 2012 year in the ScholarIQ index.
What is the open-access status of Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response?
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response has bronze oa status in the ScholarIQ index.
What is the DOI of Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response?
The DOI for Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response is on the source record.
What is the PMID of Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response?
The PMID for Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response is on the source record.
What is the OpenAlex record for Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response?
The OpenAlex for Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response is on the source record.